Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BTL-703-2

K-Number: K200382 · 2021-01-06

ApplicantBtl
Decision Date2021-01-06
Product CodeNGX
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

BTL-703-2 is the device name listed in this FDA 510(k) record. The listed applicant is Btl. It received FDA 510(k) clearance on 2021-01-06 under 510(k) number K200382. The device is classified under product code NGX. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BTL-703-2?

BTL-703-2 is a medical device that received FDA 510(k) clearance on 2021-01-06. The listed applicant is Btl. The 510(k) number is K200382.

When did BTL-703-2 receive FDA 510(k) clearance?

BTL-703-2 received FDA 510(k) clearance on 2021-01-06, under 510(k) number K200382.

Who is the listed applicant for BTL-703-2?

The FDA 510(k) record lists Btl as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BTL-703-2?

The FDA product code for BTL-703-2 is NGX.

Other records listing Btl as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: NGX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.